Compounds > papaverine

papaverine and phencyclidine

papaverine has been researched along with phencyclidine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Baxter, MG; Murphy, ER; Rodefer, JS1
Chambers, L; Chapin, DS; Harms, JF; Lebel, LA; McCarthy, SA; Menniti, FS; Schmidt, CJ; Shrikhande, A; Siuciak, JA; Wong, S1

Other Studies

5 other study(ies) available for papaverine and phencyclidine

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
PDE10A inhibition reverses subchronic PCP-induced deficits in attentional set-shifting in rats.
    The European journal of neuroscience, 2005, Volume: 21, Issue:4

    Topics: Analysis of Variance; Animals; Attention; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Conditioning, Operant; Discrimination Learning; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Male; Papaverine; Phencyclidine; Phosphodiesterase Inhibitors; Rats; Rats, Long-Evans

2005
Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis.
    Neuropharmacology, 2006, Volume: 51, Issue:2

    Topics: Animals; Antipsychotic Agents; Avoidance Learning; Catalepsy; Central Nervous System Stimulants; Corpus Striatum; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Cyclic GMP; Dendritic Spines; Dextroamphetamine; Drug Synergism; Excitatory Amino Acid Antagonists; Extracellular Signal-Regulated MAP Kinases; Haloperidol; Mice; Mice, Knockout; Motor Activity; Papaverine; Phencyclidine; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Phosphorylation; Rats

2006